Baslan, Timour
Morris, John P. IV
Zhao, Zhen
Reyes, Jose
Ho, Yu-Jui
Tsanov, Kaloyan M.
Bermeo, Jonathan http://orcid.org/0000-0002-9553-9222
Tian, Sha
Zhang, Sean
Askan, Gokce
Yavas, Aslihan http://orcid.org/0000-0002-8408-3063
Lecomte, Nicolas
Erakky, Amanda
Varghese, Anna M.
Zhang, Amy
Kendall, Jude
Ghiban, Elena
Chorbadjiev, Lubomir
Wu, Jie http://orcid.org/0000-0002-0989-8115
Dimitrova, Nevenka
Chadalavada, Kalyani
Nanjangud, Gouri J. http://orcid.org/0000-0002-8547-1957
Bandlamudi, Chaitanya
Gong, Yixiao
Donoghue, Mark T. A.
Socci, Nicholas D.
Krasnitz, Alex
Notta, Faiyaz
Leach, Steve D. http://orcid.org/0000-0002-2689-1871
Iacobuzio-Donahue, Christine A. http://orcid.org/0000-0002-4672-3023
Lowe, Scott W. http://orcid.org/0000-0002-5284-9650
Article History
Received: 6 June 2021
Accepted: 6 July 2022
First Online: 17 August 2022
Competing interests
: S.W.L. is a founder and member of the scientific advisory board of Blueprint Medicines, Mirimus, ORIC Pharmaceuticals and Faeth Therapeutics, and is on the scientific advisory board of Constellation Pharmaceuticals and PMV Pharmaceuticals. S.D.L. is on the scientific advisory board of Nybo Therapeutics and Episteme Prognostics. The other authors declare no competing interests.